HPV Newsletters

Insight HPV for PCPs - Summer 2005

Issue Date: June 30, 2005    Expires: June 30, 2008

This issue of Insight HPV reviews several case-based studies that illustrate the application of these new screening recommendations, as well as the diagnosis and treatment of condyloma acuminata (genital warts), the most easily recognized sign of genital HPV infection. This issue also features answers to several provocative questions posed at a series of HPV webcasts that aired this spring.

This program is designated for a maximum of 0.5 credits in category 1 of the Physician's Recognition Award of the American Medical Association.

Release Date: June 30, 2005
Expiration Date: June 30, 2008

Learning Objectives

After reading this publication, the participant should be able to:

• Integrate into practice current guidelines and recommendations about Papanicolaou (Pap) screening, particularly in regard to frequency of screening
• Identify the appropriate use of the human papillomavirus (HPV) DNA test as a diagnostic tool
• Evaluate diagnostic and treatment strategies for genital warts

Faculty

Jeffrey Lin, MD, FACOG

Associate Professor Director, Divisions of Gynecologic Oncology and General Obstetrics and Gynecology Chief, Gynecologic Surgery The George Washington University Medical Center Washington, DC
Disclosures: Dr. Lin has no potential conflicts of interest to disclose.

Martin Mahoney, MD, PhD

Associate Professor of Family Medicine
Assistant Research Professor of Epidemiology
Chair, Department of Health Behavior
Division of Cancer Prevention and Population Sciences
Roswell Park Cancer Institute
University at Buffalo
Buffalo, NY
Disclosures: Dr. Mahoney has served on an advisory board for Merck & Co.

Kevin Ault, MD

Associate Professor
Department of Obstetrics and Gynecology
University of Iowa Hospitals and Clinics
Iowa City, IA
Disclosures: Dr. Ault has received grant/research support from Merck & Co., GlaxoSmithKline, 3M, and Procter & Gamble Pharmaceuticals. Dr. Ault has served as a consultant to Merck & Co., 3M, and GlaxoSmithKline. Dr. Ault also has served on an advisory board for Merck & Co. Martin C. Mahoney, MD, PhD

About this CME Activity

Please read the publication, reflection on its content, complete the CME Self-Assessment and CME Evaluation and return them to the address indicated. Upon receipt, your certificate of completion will be sent to you with the correct answers to the CME Self-Assessment. The estimated time a leaner will need to complete this self study activity is .5 hours.